Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Return on Capital Employed: 2009-2021

Historic Return on Capital Employed for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to -0.33%.

  • Avadel Pharmaceuticals' Return on Capital Employed fell 38.00% to -0.36% in Q4 2021 from the same period last year, while for Dec 2021 it was -0.36%, marking a year-over-year decrease of 38.00%. This contributed to the annual value of -0.33% for FY2021, which is 36.00% down from last year.
  • As of FY2021, Avadel Pharmaceuticals' Return on Capital Employed stood at -0.33%, which was down 1,331.92% from 0.03% recorded in FY2020.
  • Over the past 5 years, Avadel Pharmaceuticals' Return on Capital Employed peaked at 0.55% during FY2017, and registered a low of -0.57% during FY2018.
  • In the last 3 years, Avadel Pharmaceuticals' Return on Capital Employed had a median value of -0.18% in 2019 and averaged -0.16%.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Return on Capital Employed spiked by 58bps in 2017 and then crashed by 112bps in 2018.
  • Avadel Pharmaceuticals' Return on Capital Employed (Yearly) stood at 0.55% in 2017, then slumped by 112bps to -0.57% in 2018, then soared by 39bps to -0.18% in 2019, then climbed by 21bps to 0.03% in 2020, then crashed by 36bps to -0.33% in 2021.